Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback